Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 45-52

  Resende Co, T ^a   Hirsch, C S ^b   Toossi, Z ^b,c   Dietze, R ^a   Ribeiro Rodrigues, R ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

Anti TB therapy; IFN ; IL 10; Immune response; Intestinal helminths; Tuberculosis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HELMINTH; HELMINTHIASIS; HUMAN; IMMUNE RESPONSE; INTESTINE INFECTION; LEUKOCYTE; LEUKOCYTE COUNT; LUNG DISEASE; LUNG TUBERCULOSIS; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; PHENOTYPE; PRIORITY JOURNAL; SUPERINFECTION;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HELMINTHIASIS; HUMANS; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; INTESTINAL DISEASES, PARASITIC; LEUKOCYTES; MALE; MYCOBACTERIUM TUBERCULOSIS; STATISTICS, NONPARAMETRIC; TUBERCULOSIS;

EID: 33845504742     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03247.x     Document Type: Article

References (43)

1. World Health Organization (WHO). WHO annual report on global TB control - summary. Wkly Epidemiol Rec 2003; 78:122-8.
2. Finkelman FD, Shea-Donohue T, Goldhill J et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodentmodels. Annu Rev Immunol 1997; 15:505-33 [Review].
3. Bethony J, Brooker S, Albonico M et al. Soil-transmitted helminth infections: ascariasis, trichuriasis and hookworm. Lancet 2006; 367:1521-32.
4. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26:487-97.
5. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 1996; 103:239-43.
6. Kalinkovich A,Weisman Z, Greenberg Z et al. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol 1998; 114:414-21.
7. Borkow G, Leng Q, Weisman Z et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000; 106:1053-60.
8. Diniz LM, Zandonade E, Dietze R, Pereira FE, Ribeiro-Rodrigues R. Short report: do intestinal nematodes increase the risk for multibacillary leprosy? Am J Trop Med Hyg 2001; 65:852-4.
9. Hirsch CS, Toossi Z, Othieno C et al. Depressed T cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180:2069-73.
10. Toossi Z, Kleinhenz ME, Ellner JJ. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986; 163:1162-72.
11. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 1988; 27:187-94.
12. Zhang M, Gong J, Iyer DV, Jones BE,Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-42.
13. Torres M, Mendez-Sampeiro P, Jimenez-Zamudio L et al. Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1994; 96:75-8.
14. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 1996; 93:3193-8.
15. Gong JH, Zhang M,Modlin RL et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996; 64:913-18.
16. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 1997; 94:3926-31.
17. Stewart GR, Boussinesq M, Coulson T, Elson L,Nutman T, Bradley JE. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 1999; 117:517-23.
18. Holland MJ, Harcus YM, Riches PL,Maizels RM. Proteins secreted by the parasitic nematode Nippostrongylus brasiliensis act as adjuvants for Th2 responses. Eur J Immunol 2000; 30:1977-87.
19. Cooper PJ, Chico ME, Sandoval C et al. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis 2000; 182:1207-13.
20. Borkow G, Bentwich Z. Chronic immune activation associated with chronic helminthiasis and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev 2004; 17:1012-30.
21. Goulart IM, Penna GO, Cunha G. Immunopathology of leprosy: the complexity of the mechanisms of host immune response to Mycobacterium leprae. Rev Soc Bras Med Trop 2002; 35:365-75 [Review].
22. Abulafia J, Vignale RA. Leprosy: pathogenesis updated. Int J Dermatol 1999; 38: 321-34 [Review].
23. + CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006; 144:25-34.
24. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803-10.
25. Satoguina J, Mempel M, Larbi J et al. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 2002; 4:1291-300.
26. McKee AS, Pearce EJ. CD25+ CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173:1224-31.
27. Anonymous. Classification of pulmonary tuberculosis. In: Diagnostic standards and classification of tuberculosis. New York: National Tuberculosis and Respiratory Disease Association, 1969:68-76.
28. Ribeiro-Rodrigues R, Resende Co T, Johnson JL et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin Diagn Lab Immunol 2002; 9:818-23.
29. Lutz AV. Schistosomamansoni and the schistosomiasis, according to observations made in Brazil. Mem Inst Oswaldo Cruz 1919; 11:121-5.
30. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
31. Baermann G. A simple method for the diagnosis of Ancylostomum (Nematode) in soil. Mededeel mit h. Geneesk. Batavia: Laboratory Weltvreden Feestbundel, 1917:41-7.
32. Moraes RG. Contribution to the study of Strongyloides stercoralis and strongyloidiasis in Brazil. Rev Saude Publ 1948; 1:507-624.
33. Hirsch CS, Toossi Z, Vanham G et al. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis 1999; 179:945-53.
34. Brown M, Miiro G, Nkurunziza P et al. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am J Trop Med Hyg 2006; 74:819-25.
35. Tristao-Sa R, Ribeiro-Rodrigues R, Johnson LT, Pereira FE, Dietze R. Intestinal nematodes and pulmonary tuberculosis. Rev Soc Bras Med Trop 2002; 35:533-5.
36. Elias D, Mengistu G, Akuffo H, Britton S. Are intestinal helminths risk factors for developing active tuberculosis? Trop Med Int Health 2006; 11:551-8.
37. Onyemelukwe GC, Musa BO. T-lymphocyte subsets in patients with hookworm infection in Zaria, Nigeria. Afr J Med Med Sci 2001; 30:255-9.
38. Wright W, Bickle Q. Immune responses following experimental human hookworm infection. Clin Exp Immunol 2005; 142:398-403.
39. Pit DS, Polderman AM, Schulz-Key H, Soboslay PT. Prenatal immune priming with helminth infections: parasite-specific cellular reactivity and Th1 and Th2 cytokine responses in neonates. Allergy 2000; 55:732-9.
40. Othieno C,Hirsch CS,Hamilton BD,Wilkinson K, Ellner JJ, Toossi Z. Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10. Infect Immun 1999; 67:5730-5.
41. Campanelli AP, Roselino AM, Cavassani KA et al. CD4+ CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 2006; 193:1313-22.
42. Leng Q, Bentwich Z, Borkow G. Increased TGF-β, Cbl-b and CTLA-4 levels and immunosuppression in association with chronic immune activation. Int Immunol 2006; 18:637-44.
43. Pastrana DV, Raghavan N, FitzGerald P et al. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 1998; 66:5955-63.